Molecular Biology

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Atomic AI #Molecular Biology #RNA #Turning Science into Business

Turning science into business: Merging AI and RNA

New kids on the block, Atomic AI, recently closed a $35 million series A financing. DDW’s Diana Spencer speaks to Raphael Townshend PhD, Founder and CEO of Atomic AI, about the company’s successes so far, plans for the future and the unique approach of combining RNA structural biology and AI models. … Read More

#Exclusive Content #Start-up Zone

Lissodendoryx florida
#Molecular Biology #Organic chemistry #Parkinson's #Synthetic chemistry

Synthesised sea sponge molecule could fight Parkinson’s

Organic chemists at the University of California, Los Angeles (UCLA) have created the first synthetic version of a molecule recently discovered in a sea sponge that may have therapeutic benefits for Parkinson’s disease and similar disorders.  The molecule, known as lissodendoric acid A, appears to… Read More

#News

microRNA
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Funding #Investment #Machine learning #Molecular Biology #RNA #Start-ups

$35 million to advance AI-driven RNA structure platform

Atomic AI, a biotechnology company fusing machine learning with structural biology to unlock RNA drug discovery, launched today with a $35 million Series A round.  The financing was led by Playground Global, with participation from 8VC, Factory HQ, Greylock, NotBoring, AME Cloud Ventures, and renowned angel investors including GitHub ex-CEO… Read More

#Business & Investment #News #Start-up Zone

E coli bacteria
#Anti-inflammatory #Bacteria #Immune response #Immune system #Molecular Biology #mRNA #Preclinical investigations

Scientists use mRNA to reprogramme the immune system

University of Queensland researchers have identified a pathway in cells that could be used to reprogramme the body’s immune system to fight back against both chronic inflammatory and infectious diseases. Dr Kaustav Das Gupta and Professor Matt Sweet from UQ’s Institute for Molecular Bioscience discovered that a molecule… Read More

#News

#3D cell culture #Drug discovery #Ex Vivo #Genomics #High Content Screening #Life sciences #Molecular Biology #Precision medicine

Podcast: Finding the right cancer drug with high-content screening

This is the latest episode of the free DDW podcast, “Finding the right cancer drug with high-content screening”. It covers an article by the same name written for Volume 23, Issue 1 – Winter 2021/22 of DDW. In the article, Lassi Paavolainen, Principal Investigator at the Institute for Molecular… Read More

#News

#Drug discovery #Molecular Biology #Synthetic biology

Global advances in synthetic biology

Lu Rahman selects some recent synthetic biology innovations and the potential they hold to benefit drug discovery.  The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape. Applying the principles of engineering to biology… Read More

#Exclusive Content

#Cancer #Cancer research #Immuno-oncology #Immunotherapy #Molecular Biology #Oncology #Rare disease

Podcast: The next steps in the fight against cancer

This is the latest episode of the free DDW podcast, “The next steps in the fight against cancer”. It covers two articles written for Volume 22, Issue 4 – Fall 2021 of DDW. They are called “Accelerating research: the path forward for treating rare cancers” and “Inside combination… Read More

#News

Francis Crick Institute
#Antimicrobials #Microbiology #Molecular Biology

Research on drug tolerance revealed 

Research from the Francis Crick Institute has revealed a key mechanism that increases tolerance to drugs amongst microbial communities. The findings could help the development of more effective antifungal treatments.    Background  Antimicrobial drug resistance and tolerance occurs when bacteria, viruses, fungi or parasites no… Read More

#News

#AI #Biochemistry #Lab automation #Molecular Biology #SLAS2022

The lab of the future is now 

Listen to this article on the DDW Podcast: In the exclusive DDW & SLAS2022 supplement published ahead of SLAS2022 in Boston, US on 5-9 February, Daniel Rines, Senior Director at Strateos, shares with DDW how his role, artificial intelligence (AI), the work of Strateos and the Covid-19 pandemic have impacted the future of the lab.  Daniel Rines’ focus at Strateos is… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Drug discovery #Infectious diseases #Molecular Biology #Research

Researchers discover way to disarm potentially deadly Listeria bacteria 

University of Queensland researchers have discovered a way to block Listeria from making the proteins that allow bacteria to survive and multiply in immune cells, which can cause severe illness in pregnant women and people with compromised immune systems. The study has been published in the journal PLOS Pathogens. Read More

#News

#Drug discovery #Genomics #Life sciences #Molecular Biology

Finding the right cancer drug with high-content screening

Listen to this article on the DDW Podcast: Lassi Paavolainen, Principal Investigator at the Institute for Molecular Medicine Finland (FIMM), Vilja Pietiäinen, Adjunct Professor in Cell and Molecular Biology, and Amanda Jones, Life Science Research Strategy Leader at PerkinElmer explain how functional precision medicine using ex vivo drug testing… Read More

#Editor's Choice #News

#Cancer research #Immunotherapy #Molecular Biology

Inside combination immunotherapies for cancer 

Listen to this article on the DDW Podcast: Combination immunotherapies are one of the most exciting advanced therapy medicinal products (ATMP) being developed, with incredible potential for treating cancer, says Panagiotis Parsonidis, a molecular biologist and lead researcher at RGCC. DDW speaks to him about VAXO-Q-RE developments, a combination immunotherapy that will soon… Read More

#Cancer Research #Editor's Choice #Exclusive Content #News #Opinion

#Molecular Biology #Neuroscience #Pharmaceuticals

Novel analgesic drug is based on Nobel prize-winning discoveries 

AlzeCure Pharma says its novel clinical candidate drug ACD440 for peripheral neuropathic pain is based on the seminal discoveries of TRPV1 by Professor David Julius, for which he was awarded the Nobel Prize in Medicine 2021.  Julius, Professor and Chair of the Department of Physiology and Morris Herzstein Chair in Molecular Biology… Read More

#News

#AI #AI / data analytics / healthtech / informatics #Collaboration #Drug discovery #Molecular Biology

IBM Research and Arctoris accelerate closed loop drug discovery 

IBM Research and Arctoris are investigating the application of AI and automation to accelerate closed loop molecule discovery.   IBM Research has developed RXN for Chemistry, an online platform leveraging Natural Language Processing (NLP) architectures to automate synthetic chemistry. Representing chemical reactions via SMILES (Simplified Molecular Input Line Entry System),… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Automation / robotics #Biopharmaceuticals #Covid-19 #CRISPR #Drug discovery #Immunology / Virology & Vaccines #Lab automation #Moderna #Molecular Biology #Pfizer #Sequencing

What has 2020 taught us about lab automation?

Listen to this article on the DDW Podcast: Dr Patrick Courtney (SiLA consortium), Burkhard Schaefer (SiLA consortium/ASTM AnIML) and Oliver Peter, Senior Director, Senior Group Leader Biology Technologies and Lead Discovery, Biology, Idorsia Pharmaceuticals, look at the importance of automation in the face of global disease. As we write this, vaccines… Read More

#Covid-19 #Exclusive Content #News

#Biopharmaceutical #Molecular Biology #Whitepaper

What makes a great BioELN?

In this latest DDW whitepaper, brought to you by PerkinElmer Informatics, John Conway, is Chief Visioneer Officer at 20/15 Visioneers, tackles defining “What Makes a Great BioELN” in this thoughtful and informative industry perspective. The whitepaper covers the six high-level workflows a great BioELN must include; what the team personas… Read More

#News